Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Non-cash Items (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Non-cash Items for 5 consecutive years, with $118000.0 as the latest value for Q3 2018.

  • Quarterly Non-cash Items fell 10.56% to $118000.0 in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $118000.0 through Sep 2018, down 10.56% year-over-year, with the annual reading at $118000.0 for FY2017, 62.67% down from the prior year.
  • Non-cash Items hit $118000.0 in Q3 2018 for Armata Pharmaceuticals, down from $174578.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $2.2 million in Q2 2016 to a low of $39766.0 in Q1 2017.
  • Historically, Non-cash Items has averaged $436765.8 across 5 years, with a median of $146162.0 in 2018.
  • Biggest five-year swings in Non-cash Items: skyrocketed 2769.87% in 2016 and later tumbled 96.43% in 2017.
  • Year by year, Non-cash Items stood at $640837.0 in 2014, then tumbled by 89.53% to $67084.0 in 2015, then soared by 371.21% to $316107.0 in 2016, then plummeted by 62.67% to $118000.0 in 2017, then changed by 0.0% to $118000.0 in 2018.
  • Business Quant data shows Non-cash Items for ARMP at $118000.0 in Q3 2018, $174578.0 in Q2 2018, and $146162.0 in Q1 2018.